rTMS Effects in Patients with Co-Morbid Somatic Pain and Depressive Mood Disorders

Repetitive Transcranial Magnetic Stimulation (rTMS) is a non-invasive neuromodulation treatment that involves the induction of electrical currents in a targeted region of the brain with the ability to impact various functional processes (Chervyakov  et al., 2015). rTMS has shown to provide clinical improvement among a variety of neurological and psychiatric disorders and has been FDA-approved for treatment resistant depression (TRD). rTMS continues to undergo trials for other treatment indications including post-traumatic stress disorder (PT SD), generalized anxiety disorder (GAD), bipolar depression, schizophrenia, stroke, tinnitus, neurodegenerative disorders, and chronic and other related pain syndromes (Canadian Agency for Drugs and Technologies in Health, 2014; DosSantos et al., 2016; Galhardoni et al., 2015; Lefaucheur et al., 2014; Ni& Chen, 2015).
Source: Journal of Affective Disorders - Category: Neurology Authors: Tags: Research paper Source Type: research